Too many breaks (brakes): Pancreatic β-cell senescence leads to diabetes

Cell Cycle

Volumn 10, Issue 15, 2011, Pages 2471-2484

  Tavana, Omid ^a   Zhu, Chengming ^a  

^a UNIVERSITY OF TEXAS   (United States)

Author keywords

Cell cycle regulation; Cellular senescence; Diabetes; DNA damage; Glucose homeostasis; cells

Indexed keywords

CELL AGING; CELL CYCLE REGULATION; CELL DIFFERENTIATION; CELL DIVISION; DIABETES MELLITUS; DNA DAMAGE; ENDOCRINE CELL; GLUCOSE HOMEOSTASIS; HUMAN; INSULIN RELEASE; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL HYPERPLASIA; REVIEW; STEM CELL; TRANSCRIPTION REGULATION;

ANIMALIA;

EID: 79961106526     PISSN: 15384101     EISSN: 15514005     Source Type: Journal    
DOI: 10.4161/cc.10.15.16741     Document Type: Review

References (142)

1. Dor Y, Brown J, Martinez OI, Melton DA. Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation. Nature 2004; 429:41-6; PMID: 15129273; DOI: 10.1038/nature02520.
2. Georgia S, Bhushan A. Beta cell replication is the primary mechanism for maintaining postnatal beta cell mass. J Clin Invest 2004; 114:963-8; PMID: 15467835.
3. Teta M, Rankin MM, Long SY, Stein GM, Kushner JA. Growth and regeneration of adult beta cells does not involve specialized progenitors. Dev Cell 2007; 12:817-26; PMID: 17488631; DOI: 10.1016/j.devcel.2007.04.011.
4. Salpeter SJ, Klein AM, Huangfu D, Grimsby J, Dor Y. Glucose and aging control the quiescence period that follows pancreatic beta cell replication. Development 2010; 137:3205-13; PMID: 20823063; DOI: 10.1242/dev.054304.
5. Ackermann AM, Gannon M. Molecular regulation of pancreatic beta-cell mass development, maintenance and expansion. J Mol Endocrinol 2007; 38:193-206; PMID: 17293440; DOI: 10.1677/JME-06-0053.
6. Cozar-Castellano I, Fiaschi-Taesch N, Bigatel TA, Takane KK, Garcia-Ocana A, Vasavada R, et al. Molecular control of cell cycle progression in the pancreatic beta-cell. Endocr Rev 2006; 27:356-70; PMID: 16638909; DOI: 10.1210/er.2006-0004.
7. Heit JJ, Karnik SK, Kim SK. Intrinsic regulators of pancreatic beta-cell proliferation. Annu Rev Cell Dev Biol 2006; 22:311-38; PMID: 16824015; DOI: 10.1146/annurev.cellbio.22.010305.104425.
8. Malumbres M, Barbacid M. Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 2009; 9:153-66; PMID: 19238148; DOI: 10.1038/nrc2602.
9. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev Cell 2008; 14:159-69; PMID: 18267085; DOI: 10.1016/j.devcel.2008. 01.013.
10. Negrini S, Gorgoulis VG, Halazonetis TD. Genomic instability - an evolving hallmark of cancer. Nat Rev Mol Cell Biol 2010; 11:220-8; PMID: 20177397; DOI: 10.1038/nrm2858.
11. Campisi J. Senescent cells, tumor suppression and organismal aging: good citizens, bad neighbors. Cell 2005; 120:513-22; PMID: 15734683; DOI: 10.1016/j.cell.2005.02.003.
12. Dimri GP, Lee X, Basile G, Acosta M, Scott G, Roskelley C, et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc Natl Acad Sci USA 1995; 92:9363-7; PMID: 7568133; DOI: 10.1073/pnas.92.20.9363.
13. Debacq-Chainiaux F, Erusalimsky JD, Campisi J, Toussaint O. Protocols to detect senescence-associated beta-galactosidase (SA-betagal) activity, a biomarker of senescent cells in culture and in vivo. Nat Protoc 2009; 4:1798-806; PMID: 20010931; DOI: 10.1038/nprot.2009.191.
14. d'Adda di Fagagna F. Living on a break: cellular senescence as a DNA-damage response. Nat Rev Cancer 2008; 8:512-22; PMID: 18574463; DOI: 10.1038/nrc2440.
15. Campaner S, Doni M, Hydbring P, Verrecchia A, Bianchi L, Sardella D, et al. Cdk2 suppresses cellular senescence induced by the c-myc oncogene. Nat Cell Biol 2010; 12:54-9.
16. Rane SG, Dubus P, Mettus RV, Galbreath EJ, Boden G, Reddy EP, et al. Loss of Cdk4 expression causes insulin-deficient diabetes and Cdk4 activation results in beta-islet cell hyperplasia. Nat Genet 1999; 22:44-52; PMID: 10319860; DOI: 10.1038/8751.
17. Tsutsui T, Hesabi B, Moons DS, Pandolfi PP, Hansel KS, Koff A, et al. Targeted disruption of CDK4 delays cell cycle entry with enhanced p27(Kip1) activity. Mol Cell Biol 1999; 19:7011-9; PMID: 10490638.
18. Kushner JA, Ciemerych MA, Sicinska E, Wartschow LM, Teta M, Long SY, et al. Cyclins D2 and D1 are essential for postnatal pancreatic beta-cell growth. Mol Cell Biol 2005; 25:3752-62; PMID: 15831479; DOI: 10.1128/MCB.25.9.3752-62. 2005.
19. Cozar-Castellano I, Takane KK, Bottino R, Balamurugan AN, Stewart AF. Induction of beta-cell proliferation and retinoblastoma protein phosphorylation in rat and human islets using adenovirus-mediated transfer of cyclin-dependent kinase-4 and cyclin D1. Diabetes 2004; 53:149-59; PMID: 14693709; DOI: 10.2337/diabetes.53.1.149.
20. He LM, Sartori DJ, Teta M, Opare-Addo LM, Rankin MM, Long SY, et al. Cyclin D2 protein stability is regulated in pancreatic beta-cells. Mol Endocrinol 2009; 23:1865-75; PMID: 19628581; DOI: 10.1210/me.2009-0057.
21. Zhang X, Gaspard JP, Mizukami Y, Li J, Graeme-Cook F, Chung DC. Overexpression of cyclin D1 in pancreatic beta-cells in vivo results in islet hyperplasia without hypoglycemia. Diabetes 2005; 54:712-9; PMID: 15734847; DOI: 10.2337/diabetes.54.3.712.
22. cip. Diabetes 2006; 55:70-7; PMID: 16380478; DOI: 10.2337/diabetes.55.01.06.db05-0632.
23. Fatrai S, Elghazi L, Balcazar N, Cras-Meneur C, Krits I, Kiyokawa H, et al. Akt induces beta-cell proliferation by regulating cyclin D1, cyclin D2 and p21 levels and cyclin-dependent kinase-4 activity. Diabetes 2006; 55:318-25; PMID: 16443763; DOI: 10.2337/diabetes.55.02.06.db05-0757.
24. Hinault C, Hu J, Maier BF, Mirmira RG, Kulkarni RN. Differential expression of cell cycle proteins during ageing of pancreatic islet cells. Diabetes Obes Metab 2008; 10:136-46; PMID: 18834441; DOI: 10.1111/j.1463-326. 2008.00947.x.
25. Martín J, Hunt SL, Dubus P, Sotillo R, Nehme-Pelluard F, Magnuson MA, et al. Genetic rescue of Cdk4 null mice restores pancreatic beta- cell proliferation but not homeostatic cell number. Oncogene 2003; 22:5261-9; PMID: 12917627; DOI: 10.1038/sj.onc.1206506.
26. Michael MD, Kulkarni RN, Postic C, Previs SF, Shulman GI, Magnuson MA, et al. Loss of insulin signaling in hepatocytes leads to severe insulin resistance and progressive hepatic dysfunction. Mol Cell 2000; 6:87-97; PMID: 10949030.
27. Okada T, Liew CW, Hu J, Hinault C, Michael MD, Krtzfeldt J, et al. Insulin receptors in beta-cells are critical for islet compensatory growth response to insulin resistance. Proc Natl Acad Sci USA 2007; 104:8977-82; PMID: 17416680; DOI: 10.1073/pnas.0608703104.
28. Georgia S, Hinault C, Kawamori D, Hu J, Meyer J, Kanji M, et al. Cyclin D2 is essential for the compensatory beta-cell hyperplastic response to insulin resistance in rodents. Diabetes 2010; 59:987-96; PMID: 20103709; DOI: 10.2337/db09-0838.
29. Araki E, Lipes MA, Patti ME, Bruning JC, Haag B, 3rd, Johnson RS, et al. Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene. Nature 1994; 372:186-90; PMID: 7526222; DOI: 10.1038/372186a0.
30. Chung DC, Brown SB, Graeme-Cook F, Seto M, Warshaw AL, Jensen RT, et al. Overexpression of cyclin D1 occurs frequently in human pancreatic endocrine tumors. J Clin Endocrinol Metab 2000; 85:4373-8; PMID: 11095482; DOI: 10.1210/jc.85.11.4373.
31. Geng Y, Yu Q, Sicinska E, Das M, Schneider JE, Bhattacharya S, et al. Cyclin E ablation in the mouse. Cell 2003; 114:431-43; PMID: 12941272; DOI: 10.1016/S0092-8674(03)00645-7.
32. Liu D, Matzuk MM, Sung WK, Guo Q, Wang P, Wolgemuth DJ. Cyclin A1 is required for meiosis in the male mouse. Nat Genet 1998; 20:377-80; PMID: 9843212; DOI: 10.1038/3855.
33. Song WJ, Schreiber WE, Zhong E, Liu FF, Kornfeld BD, Wondisford FE, et al. Exendin-4 stimulation of cyclin A2 in beta-cell proliferation. Diabetes 2008; 57:2371-81; PMID: 18544709; DOI: 10.2337/db07-1541.
34. Mettus RV, Rane SG. Characterization of the abnormal pancreatic development, reduced growth and infertility in Cdk4 mutant mice. Oncogene 2003; 22:8413-21; PMID: 14627982; DOI: 10.1038/sj.onc.1206888.
35. Sugimoto M, Nakamura T, Ohtani N, Hampson L, Hampson IN, Shimamoto A, et al. Regulation of CDK4 activity by a novel CDK4-binding protein, p34(SEI-1). Genes Dev 1999; 13:3027-33; PMID: 10580009; DOI: 10.1101/gad.13.22.3027.
36. Fernandez-Marcos PJ, Pantoja C, Gonzalez-Rodriguez A, Martin N, Flores JM, Valverde AM, et al. Normal proliferation and tumorigenesis but impaired pancreatic function in mice lacking the cell cycle regulator sei1. PLoS ONE 2010; 5:8744; PMID: 20090907; DOI: 10.1371/journal.pone.0008744.
37. Wölfel T, Hauer M, Schneider J, Serrano M, Wolfel C, Klehmann-Hieb E, et al. A p16INK4a-insensitive CDK4 mutant targeted by cytolytic T lymphocytes in a human melanoma. Science 1995; 269:1281-4; PMID: 7652577; DOI: 10.1126/science.7652577.
38. INK4abinding domain of CDK4 in familial melanoma. Nat Genet 1996; 12:97-9; PMID: 8528263; DOI: 10.1038/ng0196-97.
39. Sotillo R, Dubus P, Martin J, de la Cueva E, Ortega S, Malumbres M, et al. Wide spectrum of tumors in knock-in mice carrying a Cdk4 protein insensitive to INK4 inhibitors. EMBO J 2001; 20:6637-47; PMID: 11726500; DOI: 10.1093/emboj/20.23.6637.
40. Hino S, Yamaoka T, Yamashita Y, Yamada T, Hata J, Itakura M. In vivo proliferation of differentiated pancreatic islet beta cells in transgenic mice expressing mutated cyclin-dependent kinase 4. Diabetologia 2004; 47:1819-30; PMID: 15480536; DOI: 10.1007/s00125-004-1522-4.
41. Lee GH, Proenca R, Montez JM, Carroll KM, Darvishzadeh JG, Lee JI, et al. Abnormal splicing of the leptin receptor in diabetic mice. Nature 1996; 379:632-5; PMID: 8628397; DOI: 10.1038/379632a0.
42. Miyawaki K, Inoue H, Keshavarz P, Mizuta K, Sato A, Sakamoto Y, et al. Transgenic expression of a mutated cyclin-dependent kinase 4 (CDK4/R24C) in pancreatic beta-cells prevents progression of diabetes in db/db mice. Diabetes Res Clin Pract 2008; 82:33-41; PMID: 18678431; DOI: 10.1016/j.diabres.2008.06. 014.
43. Lee JH, Jo J, Hardikar AA, Periwal V, Rane SG. Cdk4 regulates recruitment of quiescent beta-cells and ductal epithelial progenitors to reconstitute beta-cell mass. PLoS ONE 2010; 5:8653; PMID: 20084282; DOI: 10.1371/journal. pone.0008653.
44. Pelengaris S, Khan M, Evan GI. Suppression of Myc-induced apoptosis in beta cells exposes multiple oncogenic properties of Myc and triggers carcinogenic progression. Cell 2002; 109:321-34; PMID: 12015982; DOI: 10.1016/S0092-8674(02)00738-9.
45. Uchida T, Nakamura T, Hashimoto N, Matsuda T, Kotani K, Sakaue H, et al. Deletion of Cdkn1b ameliorates hyperglycemia by maintaining compensatory hyperinsulinemia in diabetic mice. Nat Med 2005; 11:175-82; PMID: 15685168; DOI: 10.1038/nm1187.
46. Zhong L, Georgia S, Tschen SI, Nakayama K, Bhushan A. Essential role of Skp2-mediated p27 degradation in growth and adaptive expansion of pancreatic beta cells. J Clin Invest 2007; 117:2869-76; PMID: 17823659; DOI: 10.1172/JCI32198.
47. Dhawan S, Tschen SI, Bhushan A. Bmi-1 regulates the Ink4a/Arf locus to control pancreatic beta-cell proliferation. Genes Dev 2009; 23:906-11; PMID: 19390085; DOI: 10.1101/gad.1742609.
48. Chen H, Gu X, Su IH, Bottino R, Contreras JL, Tarakhovsky A, et al. Polycomb protein Ezh2 regulates pancreatic beta-cell Ink4a/Arf expression and regeneration in diabetes mellitus. Genes Dev 2009; 23:975-85; PMID: 19390090; DOI: 10.1101/gad.1742509.
49. Yang J, Zhang W, Jiang W, Sun X, Han Y, Ding M, et al. p21-overexpression in the mouse beta cells leads to the improved recovery from streptozotocin-induced diabetes. PLoS ONE 2009; 4:8344; PMID: 20020058; DOI: 10.1371/journal.pone.0008344.
50. Rachdi L, Balcazar N, Elghazi L, Barker DJ, Krits I, Kiyokawa H, et al. Differential effects of p27 in regulation of beta-cell mass during development, neonatal period and adult life. Diabetes 2006; 55:3520-8; PMID: 17130500; DOI: 10.2337/db06-0861.
51. INK4c. Proc Natl Acad Sci USA 2005; 102:14659-64; PMID: 16195383; DOI: 10.1073/pnas. 0503484102.
52. Franklin DS, Godfrey VL, O'Brien DA, Deng C, Xiong Y. Functional collaboration between different cyclin-dependent kinase inhibitors suppresses tumor growth with distinct tissue specificity. Mol Cell Biol 2000; 20:6147-58; PMID: 10913196; DOI: 10.1128/MCB.20.16.6147-58.2000.
53. Crabtree JS, Scacheri PC, Ward JM, McNally SR, Swain GP, Montagna C, et al. Of mice and MEN1: Insulinomas in a conditional mouse knockout. Mol Cell Biol 2003; 23:6075-85; PMID: 12917331; DOI: 10.1128/MCB.23.17.6075-85.2003.
54. Bertolino P, Tong WM, Herrera PL, Casse H, Zhang CX, Wang ZQ. Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice. Cancer Res 2003; 63:4836-41; PMID: 12941803.
55. Karnik SK, Chen H, McLean GW, Heit JJ, Gu X, Zhang AY, et al. Menin controls growth of pancreatic beta-cells in pregnant mice and promotes gestational diabetes mellitus. Science 2007; 318:806-9; PMID: 17975067; DOI: 10.1126/science.1146812.
56. Georgia S, Bhushan A. p27 Regulates the transition of beta-cells from quiescence to proliferation. Diabetes 2006; 55:2950-6; PMID: 17065330; DOI: 10.2337/db06-0249.
57. Wagner M, Hampel B, Hutter E, Pfister G, Krek W, Zwerschke W, et al. Metabolic stabilization of p27 in senescent fibroblasts correlates with reduced expression of the F-box protein Skp2. Exp Gerontol 2001; 37:41-55; PMID: 11738146; DOI: 10.1016/S0531-5565(01)00165-6.
58. Lin HK, Chen Z, Wang G, Nardella C, Lee SW, Chan CH, et al. Skp2 targeting suppresses tumorigenesis by Arf-p53-independent cellular senescence. Nature 2010; 464:374-9; PMID: 20237562; DOI: 10.1038/nature08815.
59. Stiles BL, Kuralwalla-Martinez C, Guo W, Gregorian C, Wang Y, Tian J, et al. Selective deletion of Pten in pancreatic beta cells leads to increased islet mass and resistance to STZ-induced diabetes. Mol Cell Biol 2006; 26:2772-81; PMID: 16537919; DOI: 10.1128/MCB.26.7.2772-81.2006.
60. Crabtree JS, Scacheri PC, Ward JM, Garrett-Beal L, Emmert-Buck MR, Edgemon KA, et al. A mouse model of multiple endocrine neoplasia, type 1, develops multiple endocrine tumors. Proc Natl Acad Sci USA 2001; 98:1118-23; PMID: 11158604; DOI: 10.1073/pnas.98.3.1118.
61. Shin DM, Kucia M, Ratajczak MZ. Nuclear and Chromatin Reorganization during Cell Senescence and Aging - A Mini-Review. Gerontology 2010.
62. Yang Y, Gurung B, Wu T, Wang H, Stoffers DA, Hua X. Reversal of preexisting hyperglycemia in diabetic mice by acute deletion of the Men1 gene. Proc Natl Acad Sci USA 2010; 107:20358-63; PMID: 21059956; DOI: 10.1073/pnas.1012257107.
63. Yang Y, Wang H, Hua X. Deletion of the men1 gene prevents streptozotocin-induced hyperglycemia in mice. Exp Diabetes Res 2011; 2010:876701.
64. 1 cyclin- dependent kinases. Cell 1993; 75:805-16; PMID: 8242751; DOI: 10.1016/0092-8674(93)90499-G.
65. Abbas T, Dutta A. p21 in cancer: intricate networks and multiple activities. Nat Rev Cancer 2009; 9:400-14; PMID: 19440234; DOI: 10.1038/nrc2657.
66. CIP1/WAF1 gene in normal diploid human fibroblasts. Science 1997; 277:831-4; PMID: 9242615; DOI: 10.1126/science.277.5327.831.
67. cip is not essential for maintaining beta-cell cycle arrest or beta-cell function in vivo. Diabetes 2006; 55:3271-8; PMID: 17130470; DOI: 10.2337/db06-0627.
68. Minamino T, Orimo M, Shimizu I, Kunieda T, Yokoyama M, Ito T, et al. A crucial role for adipose tissue p53 in the regulation of insulin resistance. Nat Med 2009; 15:1082-7; PMID: 19718037; DOI: 10.1038/nm.2014.
69. Kaneto H, Kajimoto Y, Fujitani Y, Matsuoka T, Sakamoto K, Matsuhisa M, et al. Oxidative stress induces p21 expression in pancreatic islet cells: possible implication in beta-cell dysfunction. Diabetologia 1999; 42:1093-7; PMID: 10447521; DOI: 10.1007/s001250051276.
70. Chesnokova V, Wong C, Zonis S, Gruszka A, Wawrowsky K, Ren SG, et al. Diminished pancreatic {beta} cell mass in securin-null mice is caused by {beta} cell apoptosis and senescence. Endocrinology 2009.
71. Tavana O, Puebla-Osorio N, Sang M, Zhu C. Absence of p53-dependent apoptosis combined with nonhomologous end-joining deficiency leads to a severe diabetic phenotype in mice. Diabetes 2009.
72. Sone H, Kagawa Y. Pancreatic beta cell senescence contributes to the pathogenesis of type 2 diabetes in high-fat diet-induced diabetic mice. Diabetologia 2005; 48:58-67; PMID: 15624098; DOI: 10.1007/s00125-004-1605-2.
73. Miyatsuka T, Kosaka Y, Kim H, German MS. Neurogenin3 inhibits proliferation in endocrine progenitors by inducing Cdkn1a. Proc Natl Acad Sci USA 2011; 108:185-90; PMID: 21173230; DOI: 10.1073/pnas.1004842108.
74. Krishnamurthy J, Torrice C, Ramsey MR, Kovalev GI, Al-Regaiey K, Su L, et al. Ink4a/Arf expression is a biomarker of aging. J Clin Invest 2004; 114:1299-307; PMID: 15520862.
75. Nielsen GP, Stemmer-Rachamimov AO, Shaw J, Roy JE, Koh J, Louis DN. Immunohistochemical survey of p16INK4A expression in normal human adult and infant tissues. Lab Invest 1999; 79:1137-43; PMID: 10496532.
76. INK4a induces an age-dependent decline in islet regenerative potential. Nature 2006; 443:453-7; PMID: 16957737; DOI: 10.1038/nature05092.
77. Lessard J, Sauvageau G. Bmi-1 determines the proliferative capacity of normal and leukaemic stem cells. Nature 2003; 423:255-60; PMID: 12714970; DOI: 10.1038/nature01572.
78. Le Guezennec X, Bulavin DV. WIP1 phosphatase at the crossroads of cancer and aging. Trends Biochem Sci 2010; 35:109-14; PMID: 19879149; DOI: 10.1016/j.tibs.2009.09.005.
79. Bulavin DV, Phillips C, Nannenga B, Timofeev O, Donehower LA, Anderson CW, et al. Inactivation of the Wip1 phosphatase inhibits mammary tumorigenesis through p38 MAPK-mediated activation of the p16(Ink4a)-p19(Arf ) pathway. Nat Genet 2004; 36:343-50; PMID: 14991053; DOI: 10.1038/ng1317.
80. MAPK controls expression of multiple cell cycle inhibitors and islet proliferation with advancing age. Dev Cell 2009; 17:142-9; PMID: 19619499; DOI: 10.1016/j.devcel.2009.05.009.
81. Rankin MM, Kushner JA. Adaptive beta-cell proliferation is severely restricted with advanced age. Diabetes 2009; 58:1365-72; PMID: 19265026; DOI: 10.2337/db08-1198.
82. Tschen SI, Dhawan S, Gurlo T, Bhushan A. Age-dependent decline in beta-cell proliferation restricts the capacity of beta-cell regeneration in mice. Diabetes 2009; 58:1312-20; PMID: 19228811; DOI: 10.2337/db08-1651.
83. Rankin MM, Kushner JA. Aging induces a distinct gene expression program in mouse islets. Islets 2010; 2:345-52; PMID: 21099336; DOI: 10.4161/isl.2.6.13376.
84. Halvorsen TL, Beattie GM, Lopez AD, Hayek A, Levine F. Accelerated telomere shortening and senescence in human pancreatic islet cells stimulated to divide in vitro. J Endocrinol 2000; 166:103-9; PMID: 10856888; DOI: 10.1677/joe.0.1660103.
85. Testa R, Ceriello A. Pathogenetic loop between diabetes and cell senescence. Diabetes Care 2007; 30:2974-5; PMID: 17965314; DOI: 10.2337/dc07-1534.
86. Kuhlow D, Florian S, von Figura G, Weimer S, Schulz N, Petzke KJ, et al. Telomerase deficiency impairs glucose metabolism and insulin secretion. Aging (Albany NY) 2010.
87. Herbig U, Sedivy JM. Regulation of growth arrest in senescence: telomere damage is not the end of the story. Mech Ageing Dev 2006; 127:16-24; PMID: 16229875; DOI: 10.1016/j.mad.2005.09.002.
88. Blasco MA, Lee HW, Hande MP, Samper E, Lansdorp PM, DePinho RA, et al. Telomere shortening and tumor formation by mouse cells lacking telomerase RNA. Cell 1997; 91:25-34; PMID: 9335332; DOI: 10.1016/S0092-8674(01)80006-4.
89. Lee HW, Blasco MA, Gottlieb GJ, Horner JW, 2nd, Greider CW, DePinho RA. Essential role of mouse telomerase in highly proliferative organs. Nature 1998; 392:569-74; PMID: 9560153; DOI: 10.1038/33345.
90. Sahin E, Colla S, Liesa M, Moslehi J, Muller FL, Guo M, et al. Telomere dysfunction induces metabolic and mitochondrial compromise. Nature 2011.
91. Chin L, Artandi SE, Shen Q, Tam A, Lee SL, Gottlieb GJ, et al. p53 deficiency rescues the adverse effects of telomere loss and cooperates with telomere dysfunction to accelerate carcinogenesis. Cell 1999; 97:527-38; PMID: 10338216; DOI: 10.1016/S0092-8674(00)80762-X.
92. Karlseder J, Broccoli D, Dai Y, Hardy S, de Lange T. p53- and ATM-dependent apoptosis induced by telomeres lacking TRF2. Science 1999; 283:1321-5; PMID: 10037601; DOI: 10.1126/science.283.5406.1321.
93. Liew CW, Holman A, Kulkarni RN. The roles of telomeres and telomerase in beta-cell regeneration. Diabetes Obes Metab 2009; 11:21-9; PMID: 19817785; DOI: 10.1111/j.1463-326.2009.01103.x.
94. Mahaney BL, Meek K, Lees-Miller SP. Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining. Biochem J 2009; 417:639-50; PMID: 19133841; DOI: 10.1042/BJ20080413.
95. Liu G, Parant JM, Lang G, Chau P, Chavez-Reyes A, El-Naggar AK, et al. Chromosome stability, in the absence of apoptosis, is critical for suppression of tumorigenesis in Trp53 mutant mice. Nat Genet 2004; 36:63-8; PMID: 14702042; DOI: 10.1038/ng1282.
96. Sliwinska A, Sliwinski T, Kasznicki J, Drzewoski J. Effect of gliclazide on nucleotide excision repair (NER) and non-homologous DNA end joining (NHEJ) in normal and cancer cells. J Physiol Pharmacol 2010; 61:347-53; PMID: 20610866.
97. LeRoith D, Novosyadlyy R, Gallagher EJ, Lann D, Vijayakumar A, Yakar S. Obesity and type 2 diabetes are associated with an increased risk of developing cancer and a worse prognosis; epidemiological and mechanistic evidence. Exp Clin Endocrinol Diabetes 2008; 116:4-6; PMID: 18777452; DOI: 10.1055/s-2008-1081488.
98. Pan HZ, Chang D, Feng LG, Xu FJ, Kuang HY, Lu MJ. Oxidative damage to DNA and its relationship with diabetic complications. Biomed Environ Sci 2007;20:160-3; PMID: 17624192.
99. Blasiak J, Arabski M, Krupa R, Wozniak K, Zadrozny M, Kasznicki J, et al. DNA damage and repair in type 2 diabetes mellitus. Mutat Res 2004; 554:297-304; PMID: 15450427; DOI: 10.1016/j.mrfmmm.2004.05.011.
100. Gorbunova V, Seluanov A, Mao Z, Hine C. Changes in DNA repair during aging. Nucleic Acids Res 2007; 35:7466-74; PMID: 17913742; DOI: 10.1093/nar/gkm756.
101. Lebrun P, Montminy MR, Van Obberghen E. Regulation of the pancreatic duodenal homeobox-1 protein by DNA-dependent protein kinase. J Biol Chem 2005; 280:38203-10; PMID: 16166097; DOI: 10.1074/jbc.M504842200.
102. Wang Z, Moro E, Kovacs K, Yu R, Melmed S. Pituitary tumor transforming gene-null male mice exhibit impaired pancreatic beta cell proliferation and diabetes. Proc Natl Acad Sci USA 2003; 100:3428-32; PMID: 12626748; DOI: 10.1073/pnas.0638052100.
103. Chesnokova V, Melmed S. Pituitary senescence: The evolving role of Pttg. Mol Cell Endocrinol 2010.
104. Bernal JA, Roche M, Mendez-Vidal C, Espina A, Tortolero M, Pintor-Toro JA. Proliferative potential after DNA damage and non-homologous end joining are affected by loss of securin. Cell Death Differ 2008; 15:202-12; PMID: 17962814; DOI: 10.1038/sj.cdd.4402254.
105. Campisi J, Vijg J. Does damage to DNA and other macromolecules play a role in aging? If so, how? J Gerontol A Biol Sci Med Sci 2009; 64:175-8; PMID: 19228786; DOI: 10.1093/gerona/gln065.
106. Bar RS, Levis WR, Rechler MM, Harrison LC, Siebert C, Podskalny J, et al. Extreme insulin resistance in ataxia telangiectasia: defect in affinity of insulin receptors. N Engl J Med 1978; 298:1164-71; PMID: 651946; DOI: 10.1056/NEJM197805252982103.
107. Blevins LS Jr, Gebhart SS. Insulin-resistant diabetes mellitus in a black woman with ataxia-telangiectasia. South Med J 1996; 89:619-21; PMID: 8638204; DOI: 10.1097/00007611-199606000-00013.
108. Lavin MF. Ataxia-telangiectasia: from a rare disorder to a paradigm for cell signalling and cancer. Nat Rev Mol Cell Biol 2008; 9:759-69; PMID: 18813293; DOI: 10.1038/nrm2514.
109. Schalch DS, McFarlin DE, Barlow MH. An unusual form of diabetes mellitus in ataxia telangiectasia. N Engl J Med 1970; 282:1396-402; PMID: 4192270; DOI: 10.1056/NEJM197006182822503.
110. Miles PD, Treuner K, Latronica M, Olefsky JM, Barlow C. Impaired insulin secretion in a mouse model of ataxia telangiectasia. Am J Physiol Endocrinol Metab 2007; 293:70-4; PMID: 17356010; DOI: 10.1152/ajpendo.00259.2006.
111. Schneider JG, Finck BN, Ren J, Standley KN, Takagi M, Maclean KH, et al. ATM-dependent suppression of stress signaling reduces vascular disease in metabolic syndrome. Cell Metab 2006; 4:377-89; PMID: 17084711; DOI: 10.1016/j.cmet.2006.10.002.
112. Bakkenist CJ, Kastan MB. DNA damage activates ATM through intermolecular autophosphorylation and dimer dissociation. Nature 2003; 421:499- 506; PMID: 12556884; DOI: 10.1038/nature01368.
113. Ingalls AM, Dickie MM, Snell GD. Obese, a new mutation in the house mouse. J Hered 1950; 41:317-8; PMID: 14824537.
114. Razani B, Feng C, Semenkovich CF. p53 is required for chloroquine-induced atheroprotection but not insulin sensitization. J Lipid Res 2010; 51:1738-46; PMID: 20208057; DOI: 10.1194/jlr.M003681.
115. Zhou K, Bellenguez C, Spencer CC, Bennett AJ, Coleman RL, Tavendale R, et al. Common variants near ATM are associated with glycemic response to metformin in type 2 diabetes. Nat Genet 2010.
116. Nathan DM, Buse JB, Davidson MB, Ferrannini E, Holman RR, Sherwin R, et al. Medical management of hyperglycaemia in type 2 diabetes mellitus: a consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes. Diabetologia 2009; 52:17-30; PMID: 18941734; DOI: 10.1007/s00125-008-1157-y.
117. Shiloh Y. ATM and related protein kinases: safeguarding genome integrity. Nat Rev Cancer 2003; 3:155-68; PMID: 12612651; DOI: 10.1038/nrc1011.
118. Zhan H, Suzuki T, Aizawa K, Miyagawa K, Nagai R. Ataxia telangiectasia mutated (ATM)-mediated DNA damage response in oxidative stress- induced vascular endothelial cell senescence. J Biol Chem 285:29662-70; PMID: 20639198; DOI: 10.1074/jbc.M110.125138.
119. Yang DQ, Kastan MB. Participation of ATM in insulin signalling through phosphorylation of eIF-4E-binding protein 1. Nat Cell Biol 2000; 2:893-8; PMID: 11146653; DOI: 10.1038/35046542.
120. Matsuoka S, Ballif BA, Smogorzewska A, McDonald ER, 3rd, Hurov KE, Luo J, et al. ATM and ATR substrate analysis reveals extensive protein networks responsive to DNA damage. Science 2007; 316:1160-6; PMID: 17525332; DOI: 10.1126/science.1140321.
121. Guo Z, Kozlov S, Lavin MF, Person MD, Paull TT. ATM activation by oxidative stress. Science 330:517-21; PMID: 20966255; DOI: 10.1126/science. 1192912.
122. Guo Z, Deshpande R, Paull TT. ATM activation in the presence of oxidative stress. Cell Cycle 9:4805-11; PMID: 21150274; DOI: 10.4161/cc.9.24.14323.
123. Robertson RP. Chronic oxidative stress as a central mechanism for glucose toxicity in pancreatic islet beta cells in diabetes. J Biol Chem 2004; 279:42351-4; PMID: 15258147; DOI: 10.1074/jbc.R400019200.
124. Robertson RP, Harmon J, Tran PO, Poitout V. Beta-cell glucose toxicity, lipotoxicity and chronic oxidative stress in type 2 diabetes. Diabetes 2004; 53:119-24; PMID: 14749276; DOI: 10.2337/diabetes.53.2007.S119.
125. Robertson R, Zhou H, Zhang T, Harmon JS. Chronic oxidative stress as a mechanism for glucose toxicity of the beta cell in type 2 diabetes. Cell Biochem Biophys 2007; 48:139-46; PMID: 17709883; DOI: 10.1007/s12013-007-0026-5.
126. Vousden KH, Prives C. Blinded by the Light: The Growing Complexity of p53. Cell 2009; 137:413-31; PMID: 19410540; DOI: 10.1016/j.cell.2009.04.037.
127. Meek DW. Tumour suppression by p53: a role for the DNA damage response? Nat Rev Cancer 2009.
128. McKenzie MD, Jamieson E, Jansen ES, Scott CL, Huang DC, Bouillet P, et al. Glucose induces pancreatic islet cell apoptosis that requires the BH3-only proteins Bim and Puma and multi-BH domain protein Bax. Diabetes 2009.
129. Gurzov EN, Germano CM, Cunha DA, Ortis F, Vanderwinden JM, Marchetti P, et al. Puma activation contributes to pancreatic beta cell apoptosis induced by pro-inflammatory cytokines and endoplasmic reticulum stress. J Biol Chem 2010.
130. Banin S, Moyal L, Shieh S, Taya Y, Anderson CW, Chessa L, et al. Enhanced phosphorylation of p53 by ATM in response to DNA damage. Science 1998; 281:1674-7; PMID: 9733514; DOI: 10.1126/science.281.5383.1674.
131. Canman CE, Lim DS, Cimprich KA, Taya Y, Tamai K, Sakaguchi K, et al. Activation of the ATM kinase by ionizing radiation and phosphorylation of p53. Science 1998; 281:1677-9; PMID: 9733515; DOI: 10.1126/science.281.5383.1677.
132. Armata HL, Golebiowski D, Jung DY, Ko HJ, Kim JK, Sluss HK. Requirement of the ATM/p53 tumor suppressor pathway for glucose homeostasis. Mol Cell Biol 2010; 30:5787-94; PMID: 20956556; DOI: 10.1128/MCB.00347-10.
133. Nyblom HK, Bugliani M, Fung E, Boggi U, Zubarev R, Marchetti P, et al. Apoptotic, regenerative and immune-related signaling in human islets from type 2 diabetes individuals. J Proteome Res 2009; 8:5650-6; PMID: 19852514; DOI: 10.1021/pr9006816.
134. Maier B, Gluba W, Bernier B, Turner T, Mohammad K, Guise T, et al. Modulation of mammalian life span by the short isoform of p53. Genes Dev 2004; 18:306-19; PMID: 14871929; DOI: 10.1101/gad.1162404.
135. Hinault C, Kawamori D, Liew CW, Maier B, Hu J, Keller SR, et al. {Delta}40 Isoform of p53 Controls {beta}-Cell Proliferation and Glucose Homeostasis in Mice. Diabetes 2011.
136. Allison J, Campbell IL, Morahan G, Mandel TE, Harrison LC, Miller JF. Diabetes in transgenic mice resulting from overexpression of class I histocompatibility molecules in pancreatic beta cells. Nature 1988; 333:529-33; PMID: 3287175; DOI: 10.1038/333529a0.
137. Nam SY, Lee MK, Sabapathy K. The tumour-suppressor p53 is not required for pancreatic beta cell death during diabetes and upon irradiation. J Physiol 2008; 586:407-17; PMID: 18006584; DOI: 10.1113/jphysiol.2007.142612.
138. Allison J, Malcolm L, Culvenor J, Bartholomeusz RK, Holmberg K, Miller JF. Overexpression of beta 2-microglobulin in transgenic mouse islet beta cells results in defective insulin secretion. Proc Natl Acad Sci USA 1991; 88:2070-4; PMID: 2006144; DOI: 10.1073/pnas.88.6.2070.
139. Harvey M, Vogel H, Lee EY, Bradley A, Donehower LA. Mice deficient in both p53 and Rb develop tumors primarily of endocrine origin. Cancer Res 1995; 55:1146-51; PMID: 7867001.
140. Williams BO, Remington L, Albert DM, Mukai S, Bronson RT, Jacks T. Cooperative tumorigenic effects of germline mutations in Rb and p53. Nat Genet 1994; 7:480-4; PMID: 7951317; DOI: 10.1038/ng0894-480.
141. Donehower LA, Harvey M, Slagle BL, McArthur MJ, Montgomery CA Jr, Butel JS, et al. Mice deficient for p53 are developmentally normal but susceptible to spontaneous tumours. Nature 1992; 356:215-21; PMID: 1552940; DOI: 10.1038/356215a0.
142. Junttila MR, Evan GI. p53 - a Jack of all trades but master of none. Nat Rev Cancer 2009.